Utama › Kanser Kulit › Massachusetts
Kajian klinikal Kanser Kulit di Massachusetts
10 kajian untuk Kanser Kulit sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- Northeast Dermatology Associates, Beverly
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06585410Cryoablation+Ipilimumab+Nivolumab in Melanoma
- Massachusetts General Hospital Cancer Center, Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT05779423Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07426484Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT06947928ctDNA in Cutaneous Squamous Cell Carcinoma
- Massachusetts Eye and Ear, Boston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Mac 2026 · NCT06875609Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
- Massachusetts General Hospital, Boston
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mac 2026 · NCT06171750TIL Therapy in cSCC and MCC
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT07288073SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Worcester
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2025 · NCT06664151Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.